Dr Vishal Gulati, a member of Reuben College’s Advisory Board, has been elected as one of 54 new Fellows of the Academy of Medical Sciences for his exceptional contributions to translational medicine.
As one of the most prestigious medical research organisations globally, The Academy of Medical Sciences and its fellows include many of the most influential scientists in the UK and worldwide. Dr Gulati's election is a recognition of the increasingly important role that translational medicine plays in speeding up the testing and delivery of novel therapeutics and medical devices. As a doctor, investor, advocate, and mentor, Dr Gulati has played a pivotal role in developing thriving health and tech ecosystems in the UK, US and India.
On his election, he says:
I am grateful for the privilege of supporting scientists in translating their discoveries into clinical applications used by millions of people worldwide. With faster technologies and deeper insights into disease, we’re living through a golden age of biomedical discovery. The next step is clear - build a stronger bridge from idea to impact so the fruits of science can reach patients faster. This aligns strongly with the mission of the Academy of Medical Sciences and I am grateful for their recognition.
Dr Gulati has mentored hundreds of scientists in commercialising their discoveries, leading to many successes. His early conviction in digital health and AI-driven drug discovery led to the funding of pioneering companies developing new treatments. A number of globally impactful products have been launched under Vishal's guidance, including Kheiron Medical's award-winning AI-based breast imaging product, ieso's best in class, digital mental health solutions, and Clue's women's health product, downloaded by over 100 million women worldwide.
